Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia

被引：0
|
作者：
Hwang, Steven
Wang, Yucai
Rabe, Kari
Williams-Watley, Marquise
Kenderian, Saad
Muchtar, Eli
Hampel, Paul
Kay, Neil
Koehler, Amber
Behnken, Amy
Leis, Jose
Braggio, Esteban
Shi, Min
Viswanatha, David
Van Dyke, Daniel
Slager, Susan
Parikh, Sameer
He, Rong
Ding, Wei
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1550290
引用
收藏
页码：S84 / S85
页数：2
相关论文
共 50 条
  • [41] What have we learned about TP53-mutated acute myeloid leukemia?
    Moazzam Shahzad
    Muhammad Kashif Amin
    Naval G. Daver
    Mithun Vinod Shah
    Devendra Hiwase
    Daniel A. Arber
    Mohamed A. Kharfan-Dabaja
    Talha Badar
    Blood Cancer Journal, 14 (1)
  • [42] Candidate drug screening for TP53-mutated AML
    Gwak, Daehyeon
    Kim, Dong Chan
    Jang, Heejun
    Liu, Jun
    Byun, Ja Min
    Hong, Junshik
    Shin, Dong Yeop
    Yoon, Sung-Soo
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Revealing the dark secrets of TP53-mutated AML
    Hasserjian, Robert P.
    BLOOD, 2022, 140 (01) : 8 - 10
  • [44] Overall survival in TP53-mutated AML and MDS
    Christian J. Puzo
    Karl M. Hager
    Henry M. Rinder
    Olga K. Weinberg
    Alexa J. Siddon
    Annals of Hematology, 2024, 103 (12) : 5359 - 5369
  • [45] Clinical Outcomes of Patients (pts) with TP53-Mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS): A Single Center Experience
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Hager, Karl
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Prebet, Thomas
    Halene, Stephanie
    Isufi, Iris
    Foss, Francine M.
    Huntington, Scott F.
    Kim, Tae Kon
    Pillai, Manoj M.
    Parker, Terri L.
    Neparidze, Natalia
    Bar, Noffar
    Seropian, Stuart
    Siddon, Alexa J.
    Zeidan, Amer M.
    BLOOD, 2019, 134
  • [46] Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb A.
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautham
    Pemmaraju, Naveen
    Konopleva, Marina
    Soltysiak, Kelly A.
    Pierce, Sherry R.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD ADVANCES, 2020, 4 (03) : 482 - 495
  • [47] Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study
    Visentin, Andrea
    Mauro, Francesca Romana
    Scarfo, Lydia
    Gentile, Massimo
    Farina, Lucia
    Reda, Gianluigi
    Ferrarini, Isacco
    Proietti, Giulia
    Derenzini, Enrico
    Cibien, Francesca
    Vitale, Candida
    Sanna, Alessandro
    Pietrasanta, Daniela
    Marchetti, Monia
    Murru, Roberta
    Rigolin, Gian Matteo
    Sportoletti, Paolo
    Trimarco, Valentina
    Cavarretta, Chiara Adele
    Angotzi, Francesco
    Cellini, Alessandro
    Ruocco, Valeria
    Zatta, Ivan
    Laurenti, Luca
    Molica, Stefano
    Coscia, Marta
    Ghia, Paolo
    Foa, Robin
    Cuneo, Antonio
    Trentin, Livio
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E237 - E240
  • [48] Somatic Mutations in TP53 Identified in T-Cells of Patients with TP53-mutated AML
    Issa, Ghayas C.
    Bidikian, Aram
    Ayoub, Edward
    Wang, Feng
    Mohanty, Vakul
    Leighton, Jake
    Wu, Xiaogang
    Patsilevas, Tallie
    Alaniz, Zoe
    Zarka, Jabra
    Kanagal-Shamanna, Rashmi
    Daver, Naval
    Futreal, Andy
    Konopleva, Marina
    Navin, Nicholas
    Zhang, Jianhua
    Chen, Ken
    Andreeff, Michael
    BLOOD, 2022, 140 : 6267 - 6269
  • [49] Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis
    Naval G. Daver
    Shahed Iqbal
    Camille Renard
    Rebecca J. Chan
    Ken Hasegawa
    Hao Hu
    Preston Tse
    Jiajun Yan
    Michael J. Zoratti
    Feng Xie
    Giridharan Ramsingh
    Journal of Hematology & Oncology, 16
  • [50] TP53 Aberrations in Chronic Lymphocytic Leukemia
    Trbusek, Martin
    Malcikova, Jitka
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
12345